US$ 23.65
glp-1 drug market size Trends and Global Forecasts Report 2025: A $157.5 Bn Market by 2035 glp-1 drugs pharmaceutical companies partnerships
Description
It doesnt strike quickly

Once-Weekly Efpeglenatide Dose-Range Effects on Glycemic Control and Body Weight in Patients With Type 2 Diabetes on Metformin or Drug Naive, Referenced to Liraglutide

The roller coaster ride to the first GLP-1 obesity drug While approved first as a drug for diabetes, very early on in its development, when Knudsen first began work on liraglutide she wondered if the same drug could also be used as a treatment of obesity (Molteni, Chen)

Together, these modifications improve bioavailability and decelerate renal clearance [900]
